You have reached your daily news limit

Please log in to continue


1 in 3 South Korean Covid-19 patients improve with remdesivir

Remdesivir has been at the forefront of the global battle against Covid-19 after the intravenously administered medicine helped shorten hospital recovery times in a US clinical trial
সম্পূর্ণ আর্টিকেলটি পড়ুন